期刊文献+

~1H-MRS在高级别胶质瘤与单发转移瘤鉴别诊断的初步研究 被引量:2

The Study to Identify High-grade Primary Gliomas and Solitary Metastases with ~1-MRS
下载PDF
导出
摘要 目的:探讨1H-MRS对高级别胶质瘤与单发转移瘤鉴别诊断的临床应用价值。材料与方法:27例经病理证实或临床证实患者,高级别胶质瘤16例,单发转移瘤11例。采用单体素波谱采集或二维波谱化学位移成像对肿瘤瘤体及瘤周进行波谱采集。数据分析采用STUDENTt检验,对有显著性差异者进行均数比较。结果:高级别胶质瘤与单发转移瘤瘤体CHO/Cr值均升高,二者存在显著性差异;高级别胶质瘤瘤周CHO/Cr值升高。转移瘤瘤周CHO/Cr值无明显升高。NAA/Cr值二者间均无显著性差异。结论:高级别胶质瘤与转移瘤瘤体与瘤周CHO/Cr值存在显著性差异,对二者鉴别有重要意义。 Purpose: To determine wbether ^1H- MRS can be used to differentiate high- grade primary gliomas and solitary metastases on basis of difference in metabolite levels both in the tumor and peritumoral region. Materials and Methods: 27 patients with a solitary brain tttmor (16 gliomas,11 metastases) underwent ^1H- MRS imaging before surgical treatment, stereotaetie biopsy and other therapy. All the patients were evident by patliology or tbe following examination and survey. Spectra from the erdaeneing tumor, tbe peritumoral region and normal brain was obtained feom the. two - dimensional spectroscopic MR imaging the student t test was used to determine ff there was significant statistical differece in metabolic ratios between high - grade gliomas and metastases. Results: The ratio CHO/Cr of tumors was elevated in gliomas and metastases, the difference was significant (P 〈 0.05). The ratio for choline to ereatine was elevated intbe peritumoral region of gliomas but not in metastases. While the ratio of NAA/Cr in the peritumoral region of gliomas and metastases was not statistical significant (P 〉 0.05). Conclusion: Tbe ratios CHO/Cr in tumor and peritumoral region of high - grade gliomas and metastases have significant statistical differece.
出处 《现代医用影像学》 2007年第3期106-108,共3页 Modern Medical Imageology
关键词 磁共振波谱 化学位移 胶质瘤 转移瘤 水肿 代谢产物 H- MRS Enable distinction the two.
  • 相关文献

参考文献9

  • 1吴光耀,孙骏谟,田志雄,黄雄,张在鹏,谢长清.质子磁共振波谱在脑肿瘤中的应用研究[J].临床放射学杂志,2001,20(4):271-275. 被引量:18
  • 2Sijens PE, Knopp M V, .Brunetδti A, et al.^1H- MR spectroscopy in patients with metastatic brain tumors: a multicenter study, magnet resonance Med, 1995 ; 33 (6) : 818 - 826.
  • 3Flani A, Giovanna C, Orlggi D, et al. Proton magnetic spectrscopy and intracranial tumors: Clinical perspective. J, Neurology 1996; 243: 706-714.
  • 4Brulm H, Frahm J, Gyngell Ml et al. Noninvasive differentiation of tumors with use of lacalized ^1H- MR spectroscopy in VLVO: initial experience in patients with eerebraltumors, Radiology, 1989; 127 (2): 541-548.
  • 5Knopp E A, Cha s, Johnson G, et al. Glial Neoplasms: dy, namic contrast - enhenced T2*-weighted MR imaging. Radiology, 1999; 211 (3): 791-798.
  • 6Chen Cy, Limg JF, et al. Proton magnetic resonancespectroscopy- guided biopsy for cerebral glial tumors. J Formos Med Assoc. 2004; 104 (6): 448-458.
  • 7Burtscher l M, Skagerberg G, Geijer B, et al. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intraccranial mass lessions characterized by stereotatic biopsy findings. AJNR Am J, Neuroradiology, 2000; 21 (1): 84- 93.
  • 8Zhang M, Olsson Y. Hematogenous matastases of peritumoral brainchanes: a review. J Neurooncol, 1997; 35 (1): 81- 89.
  • 9Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopy imaging: clinical relevance, Radiology 1992; 185 (3) : 675 - 686.

二级参考文献14

  • 1[1]Bruhn H, Frahm J, Michael LG,et al. Noninvasive differentiation of tumors with use of localized H-1 spectroscopy in vivo: Initial experience in patients with cerebral tumors. Radiology, 1989, 172:541
  • 2[2]Robert D, Lai PH, Smith JS. Single voxel proton brain spectroscopy Exam (Probe/SV) in patients with primary brain tumors. AJR, 1996, 167:201
  • 3[3]Knock G, Mukherjisk L. Clinical application of proton MR spectroscopy. AJNR, 1996, 172:541
  • 4[4]Peptone H, Gupta RK, Roy R,et al. Characterization of intra-cranial man lesions with in vivo proton MR spectroscopy. AJNR, 1995, 16:1593
  • 5[5]Henny DJ, Ernst T. Human brain tumors assessment with in vivo proton MR spectroscopy. Radiology, 1993, 186:745
  • 6[6]Luyten PR, Marien AJH, Heindel W,et al. Metabolic imaging of patient with intra-cranial tumors: 1HMR spectroscopic imaging and PET. Radiology, 1990, 176:791
  • 7[7]Kugel H, Heindel W, Ernestus RI,et al. Human brain tumors: Spectral patterns detected with localized 1HMR spectroscopy. Radiology, 1992, 183:701
  • 8[8]Kugel AC, Donnelly SM, Halliday W,et al. Mobile lipids and metabolic heterogeneity of brain tumor as detectable by in vivo 1HMR spectroscopy. HMR Biomed, 1994, 7:172
  • 9[9]Kuesel AC, Sutherland GR, Halliday W,et al. 1HMRS of high grade astrocytomas mobile lipid accumulation in necrotic tissue. NMR Biomed, 1994, 7:149
  • 10[10]Gober JR. Noninvasive tissue characterization of brain tumor and radiation therapy using magnetic resonance spectroscopy. Neuroimag Clin North AM, 1993, 3:779

共引文献17

同被引文献12

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部